Stephanie M. Gustavson

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Lindsay E. Clegg, Robert C. Penland, Srinivas Bachina et al. · Cardiovascular Diabetology · 2019 · 77 citations · Full text

Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs

Makoto Nishizawa, Mary Courtney Moore, Masakazu Shiota et al. · American Journal of Physiology-Endocrinology and Metabolism · 2003 · 69 citations

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

Robert J. Mentz, M. Angelyn Bethel, Stephanie M. Gustavson et al. · American Heart Journal · 2017 · 62 citations · Full text

Cardiovascular Disease, Health Policy, Myocardial Infarction +9

Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog

Stephanie M. Gustavson, Chang An Chu, Makoto Nishizawa et al. · American Journal of Physiology-Endocrinology and Metabolism · 2003 · 61 citations

Glucose Production, Concurrent Hormone Administration, Insulin Signaling +16